Drawing for QRNA

USPTO serial 79164306

QRNA

Reviewed by CopyMark Law Group

Reg. 4853377Status 404
Filing date
Status date
Registration date
Nov 17, 2015
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QRNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical compounds for scientific or research purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; veterinary preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; sanitary preparations for medical purposes; dietetic substances, namely, sugar and sugar substitutes adapted for medical useSECTION 71 - CANCELLED—
042Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; research and analysis in the field of medicine; biotechnological, chemical and pharmacological laboratory services, namely, scientific and technological research in the field of the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi-finished and finished preparations; academic research services in the medical and biochemical field; laboratory technician services, namely, research and analysis in the field of chemistry; engineering services; research and development in the field of biotechnology; research, development and testing of pharmaceutical and biochemical semifinished products, in particular for use in medicines; research, development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; research and development services relating to new drug targetsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 1, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 18, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 24, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 24, 2023INPCINVALIDATION PROCESSED—
Feb 3, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 3, 2022C71TCANCELLED SECTION 71—
Nov 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 1, 2016ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 11, 2016FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 19, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 19, 2016FIMPFINAL DISPOSITION PROCESSED—
Feb 17, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 29, 2015CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 1, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 12, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 12, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 27, 2015ALIEASSIGNED TO LIE—
Jul 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 29, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 2, 2015RFNTREFUSAL PROCESSED BY IB—
May 11, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 11, 2015RFRRREFUSAL PROCESSED BY MPU—
May 9, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 9, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 8, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2015DOCKASSIGNED TO EXAMINER—
May 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance